Literature DB >> 31009357

Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage.

Barbara Casolla1, Solène Moulin1, Maéva Kyheng2, Hilde Hénon1, Julien Labreuche2, Didier Leys1, Christophe Bauters3, Charlotte Cordonnier1.   

Abstract

Background and Purpose- We aimed to determine incidences and predictors of major vascular events in intracerebral hemorrhage (ICH) survivors. Methods- We did a prospective observational cohort study in patients with spontaneous ICH from the Prognosis of Intracerebral Hemorrhage cohort in Lille, France. We studied incidences and predictors of long-term vascular events (cerebral and extracerebral, ischemic and hemorrhagic) in patients alive at 30 days with a prespecified subgroup analysis according to ICH location. We performed multivariable analyses (competing risk analyses, with death during follow-up as a competing event). Results- From the 560 patients with spontaneous ICH enrolled between November 2004 and March 2009, we included 310 patients (median age, 70 years). Eighty-two patients presented at least 1 major vascular event leading to an incidence rate of 20.0% (95% CI, 15.7-24.7) at 5 years after ICH. In the overall cohort, ischemic events were more frequent than hemorrhagic events. However, the incidence strikingly differed according to ICH location: deep ICH was associated with future ischemic events (subhazard ratio, 1.85; 95% CI, 1.01-3.40), whereas lobar ICH with hemorrhagic events (subhazard ratio, 2.38; 95% CI, 1.17-4.86). In deep ICH, the incidence of ischemic events at 5 years was 6× higher than the incidence of hemorrhagic events. Conclusions- ICH survivors are at high risk of both cerebral and extracerebral vascular events. The ischemic or hemorrhagic risk profile varies according to the index ICH location with a stronger ischemic risk in deep ICH. Secondary prevention, tailored on ICH location, should target not only cerebral recurrences but also extracerebral vascular events.

Entities:  

Keywords:  France; cerebral hemorrhage; cohort studies; prognosis; vascular events

Mesh:

Substances:

Year:  2019        PMID: 31009357     DOI: 10.1161/STROKEAHA.118.024449

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  25 in total

1.  A nomogram to predict the risk of early postoperative ischemic events in patients with spontaneous intracranial hematoma.

Authors:  Junhua Yang; Kaiwen Wang; Qingyuan Liu; Shaohua Mo; Jun Wu; Shuzhe Yang; Rui Guo; Yi Yang; Jiaming Zhang; Yang Liu; Yong Cao; Shuo Wang
Journal:  Neurosurg Rev       Date:  2021-04-20       Impact factor: 3.042

2.  Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.

Authors:  Santosh B Murthy; Ivan Diaz; Xian Wu; Alexander E Merkler; Costantino Iadecola; Monika M Safford; Kevin N Sheth; Babak B Navi; Hooman Kamel
Journal:  Stroke       Date:  2019-11-27       Impact factor: 7.914

3.  Premature vascular disease in young adult stroke: a pathology-based case series.

Authors:  Marco Pasi; Eva Rocha; Wesley Samore; Matthew P Frosch; Anand Viswanathan; Aneesh B Singhal
Journal:  J Neurol       Date:  2019-12-18       Impact factor: 4.849

4.  Hemorrhage-Induced Sphingosine Kinase 1 Contributes to Ferroptosis-Mediated Secondary Brain Injury in Intracerebral Hemorrhage.

Authors:  Xiaojun Diao; Qi Cui; Ning Tian; Zixian Zhou; Wenjing Xiang; Yanlin Jiang; Jungang Deng; Hongzhan Liao; Xiaohui Lin; Qinghua Li; Rujia Liao
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

5.  Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.

Authors:  Santosh B Murthy; Xian Wu; Ivan Diaz; Melvin Parasram; Neal S Parikh; Costantino Iadecola; Alexander E Merkler; Guido J Falcone; Stacy Brown; Alessandro Biffi; Judy Ch'ang; Jared Knopman; Philip E Stieg; Babak B Navi; Kevin N Sheth; Hooman Kamel
Journal:  Stroke       Date:  2020-03-17       Impact factor: 7.914

6.  Contribution of Racial and Ethnic Differences in Cerebral Small Vessel Disease Subtype and Burden to Risk of Cerebral Hemorrhage Recurrence.

Authors:  Juan Pablo Castello; Marco Pasi; Jessica R Abramson; Axana Rodriguez-Torres; Sandro Marini; Stacie Demel; Lee Gilkerson; Patryk Kubiszewski; Andreas Charidimou; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; M Edip Gurol; Anand Viswanathan; Christopher D Anderson; Carl D Langefeld; Matthew L Flaherty; Amytis Towfighi; Steven M Greenberg; Daniel Woo; Jonathan Rosand; Alessandro Biffi
Journal:  Neurology       Date:  2021-04-21       Impact factor: 9.910

7.  Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 Analysis.

Authors:  Santosh B Murthy; Cenai Zhang; Ajay Gupta; Sung-Min Cho; Lucia Rivera-Lara; Radhika Avadhani; Joshua Gruber; Costantino Iadecola; Guido J Falcone; Kevin N Sheth; Adnan I Qureshi; Joshua N Goldstein; Daniel F Hanley; Hooman Kamel; Wendy C Ziai
Journal:  Stroke       Date:  2021-01-20       Impact factor: 7.914

8.  Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.

Authors:  Linxin Li; Michael T C Poon; Neshika E Samarasekera; Luke A Perry; Tom J Moullaali; Mark A Rodrigues; James J M Loan; Jacqueline Stephen; Christine Lerpiniere; Maria A Tuna; Sergei A Gutnikov; Wilhelm Kuker; Louise E Silver; Rustam Al-Shahi Salman; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2021-06       Impact factor: 59.935

9.  Risk of Mortality After an Arterial Ischemic Event Among Intracerebral Hemorrhage Survivors.

Authors:  Melvin Parasram; Neal S Parikh; Alexander E Merkler; Guido J Falcone; Kevin N Sheth; Babak B Navi; Hooman Kamel; Cenai Zhang; Santosh B Murthy
Journal:  Neurohospitalist       Date:  2021-06-25

10.  Endogenous zinc protoporphyrin formation critically contributes to hemorrhagic stroke-induced brain damage.

Authors:  Rong Pan; Song Yu; Haikun Zhang; Graham S Timmins; John Weaver; Yirong Yang; Xixi Zhou; Ke Jian Liu
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-29       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.